下一代手术机器人安全实施的真实世界证据:Versius 外科注册登记首 2083 例分析
本研究基于前瞻性、多中心 Versius 外科注册登记的首批 2083 例数据,覆盖普外、结直肠、疝、妇科、泌尿及胸科等适应证。胆囊切除(n=539)、前切除术(n=162)和全腹腔镜子宫全切术(n=324)记录较多,各术式中转率、严重不良事件率和 90 天死亡率均较低,为机器人安全进入临床实践提供真实世界证据。
要点
- 首批 2083 例跨多专科注册数据显示中转、严重不良事件及 90 天死亡率均低。
- 胆囊切除、前切除和全腹腔镜子宫全切术积累病例数较多。
- 该注册登记可为机器人手术安全实施提供真实世界证据基础。
核心结论
- Versius 外科注册登记首批 2083 例分析显示,各手术适应证下中转率、严重不良事件率和 90 天死亡率均较低,支持该手术机器人安全进入临床实践。
研究设计与样本
- 前瞻性、多中心数据注册登记研究,通过安全在线平台持续收集手术结局数据,本次分析纳入 2083 例。
- 收集术前(年龄、性别、BMI、手术史、计划术式)、术中(手术时间、术中并发症、中转、出血量)及术后(住院时间、并发症、严重不良事件、重返手术室、再入院、90 天死亡)数据。
主要发现
- 注册分析纳入 2083 例,覆盖普外、结直肠、疝、妇科、泌尿和胸科适应证。
- 胆囊切除术记录 539 例,前切除术 162 例,全腹腔镜子宫全切术 324 例。
- 所有手术适应证下各术式的中转率、严重不良事件率和 90 天死亡率均较低。
临床怎么用
- 可将该注册登记的真实世界结局数据作为机器人手术安全实施和持续质量监测的参考依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To present the first report of data from the Versius Surgical Registry, a prospective, multicenter data registry with ongoing collection across numerous surgical indications, developed to accompany the Versius Robotic Surgical System into clinical practice. BACKGROUND: A data registry can be utilized to minimize risk to patients by establishing the safety and effectiveness of innovative medical devices and generating a thorough evidence base of real-world data. METHODS: Surgical outcome data were collected and inputted through a secure online platform. Preoperative data included patient age, sex, body mass index, surgical history, and planned procedures. Intraoperative data included operative time, complications during surgery, conversion from robot-assisted surgery to an alternative surgical technique, and blood loss. Postoperative outcome data included length of hospital stay, complications following surgery, serious adverse events, return to the operating room, readmission to the hospital, and mortality within 90 days of surgery. RESULTS: This registry analysis included 2083 cases spanning general, colorectal, hernia, gynecologic, urological, and thoracic indications. A considerable number of cases were recorded for cholecystectomy (n=539), anterior resection (n=162), and total laparoscopic hysterocolpectomy (n=324) procedures. The rates of conversion to an alternative technique, serious adverse events, and 90-day mortality were low for all procedures across all surgical indications. CONCLUSIONS: We report the large-scale analysis of the first 2083 cases recorded in this surgical registry, with substantial data collected for cholecystectomies, anterior resections, and total laparoscopic hysterectomies. The extensive surgical outcome data reported here provide real-world evidence for the safe implementation of the surgical robot into clinical practice.
引用
- Soumpasis I, Nashef S, Dunning J, et al. Safe Implementation of a Next-Generation Surgical Robot: First Analysis of 2,083 Cases in the Versius Surgical Registry. Ann Surg. 2023. PMID: 37036097. doi:10.1097/SLA.0000000000005871
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。